Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Dermatophytosis are the most frequent fungal infections worldwide and there have been described clinical resistance to the commonly used antifungals. Clioquinol is an antimicrobial that had the oral formulations withdrawn from the market in the 70's due report of neurotoxicity and recently has been considered as an effective alternative for treatment of dermatophytosis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>To evaluate the effect of the double and triple association between clioquinol with terbinafine and ciclopirox on clinical isolates of dermatophytes. The cytotoxicity of these associations on human leukocytes was also verified.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Checkerboard method was used to evaluate the interaction between antifungal agents. Time kill assay were used to verify fungicidal action and evaluate the combination with greater effect for TRU47 isolate. Cell viability was assessed by loss of integrity of the leukocyte membrane in order to verify the toxicity.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Synergistic interaction was observed in 42% of isolates when terbinafine was associated with clioquinol and in 50% of isolates when ciclopirox was associated with clioquinol. The triple association resulted in synergistic interaction for 75% of the isolates. Clioquinol + terbinafine and triple combination were more effective for TRU47 isolate and the combinations exhibited a time‐dependent fungicidal effect. Furthermore, the results of cell viability demonstrated that clioquinol and terbinafine combination are not cytotoxic to human leukocytes.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Clioquinol in combination with antifungals in the treatment of dermatophytosis can be a therapeutic strategy to overcome problems related to resistance, action spectrum and toxicity of the antifungal drugs used in the clinic.</p></section>

In vitro determination of the combination of ciclopirox and terbinafine in the treatment of dermatophytosis

Terbinafine versus itraconazole for treatment of dermatophyte onychomycosis: a meta-analysis

In Vitro Interaction of Itraconazole with Amphotericin B, Caspofungin, and Terbinafine Against Clinical Isolates of Trichosporon asahii

In Vitro Interactions of Micafungin with Amphotericin B, Itraconazole or Fluconazole Against the Pathogenic Phase of Penicillium Marneffei.

In vitro antidermatophytic synergism of double and triple combination of clioquinol with ciclopirox and terbinafine

In vitro susceptibility testing of the combination of terbinafine and itraconazole against dematiaceous fungi

In Vitro additive effect on griseofulvin and terbinafine combinations against multidrug-resistant dermatophytes

In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes

Activities of Terbinafine in Combination with Itraconazole and Fluconazole Against Isolates of Candida albicans In Vitro

Combination of itraconazole and terbinafine in treating sporotrichosis and their in vitro antifungal activities against Sporothrix schenckii

In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles

Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation

In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis

In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes

Comparison between the efficacy of terbinafine and itraconazole orally vs. the combination of the two drugs in treating recalcitrant dermatophytosis

In Vitro Interaction of Terbinafine with Itraconazole and Amphotericin B Against Fungi Causing Chromoblastomycosis in China.

In Vitro Testing of Amorolfine in Combination with Terbinafine and Itraconazone Against Fungal Isolates in Onychomycosis

In vitro activity of terbinafine in combinations with other antifungi drugs against clinical pathogenic fungi of vulvovaginal candidiasis

Evaluation of activity and toxicity of combining clioquinol with ciclopirox and terbinafine in alternative models of dermatophytosis

Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates

Comparative efficacy of 1% terbinafine hydrochloride cream and 1% ciclopirox olamine cream alone and in combination for the treatment of dermatophytosis